1050, chemin Sainte-Foy
Laboratoire de pathologie
Canada G1S 4L8
- Quand les gènes parlent 2019-02-05
Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast CancerArticle de revue
Anticancer Res, 37 (6), 2017.
Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factorsArticle de revue
Breast, 30 , 2016.
Is there an Upgrading to Malignancy at Surgery of Mucocele-Like Lesions Diagnosed on Percutaneous Breast Biopsy?Article de revue
Breast J, 22 (2), 2016.
Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast CancerArticle de revue
Anticancer Res, 36 (9), 2016.
Validation of EP1 Antibody Clone for Estrogen Receptor Immunohistochemistry for Breast CancerArticle de revue
Anticancer Res, 36 (1), 2016.
Physical activity, mammographic density, and age-related lobular involution among premenopausal and postmenopausal womenArticle de revue
Menopause, 22 (9), 2015.
Advantages and disadvantages of technologies for HER2 testing in breast cancer specimensArticle de revue
Am J Clin Pathol, 144 (5), 2015.
Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsyArticle de revue
Anticancer Res, 34 (3), 2014.
Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimensArticle de revue
Diagn Pathol, 8 , 2013.
Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumabArticle de revue
Anticancer Res, 33 (6), 2013.